Cargando…
Strategies to enhance monoclonal antibody uptake and distribution in solid tumors
Despite the significant resources dedicated to the development of monoclonal antibody (mAb) therapies for solid tumors, the clinical success, thus far, has been modest. Limited efficacy of mAb in solid tumors likely relates to unique aspects of tumor physiology. Solid tumors have an aberrant vascula...
Autores principales: | Bordeau, Brandon M., Balthasar, Joseph P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Compuscript
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330533/ https://www.ncbi.nlm.nih.gov/pubmed/35979855 http://dx.doi.org/10.20892/j.issn.2095-3941.2020.0704 |
Ejemplares similares
-
Dynamic Contrast-Enhanced Magnetic Resonance Imaging for the Prediction of Monoclonal Antibody Tumor Disposition
por: Bordeau, Brandon M., et al.
Publicado: (2022) -
Mechanisms of ADC Toxicity and Strategies to Increase ADC Tolerability
por: Nguyen, Toan D., et al.
Publicado: (2023) -
Monoclonal antibody therapy of solid tumors: clinical limitations and novel strategies to enhance treatment efficacy
por: Cruz, Esteban, et al.
Publicado: (2019) -
Mechanistic considerations for the use of monoclonal antibodies for cancer therapy
por: Glassman, Patrick M., et al.
Publicado: (2014) -
Monoclonal antibodies and Fc fragments for treating solid tumors
por: Eisenbeis, Andrea M, et al.
Publicado: (2012)